LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
3.160
-0.090 (-2.77%)
At close: Oct 23, 2026, 4:00 PM EDT
3.150
-0.010 (-0.32%)
After-hours: Oct 23, 2026, 7:40 PM EDT
LENZ Therapeutics Employees
LENZ Therapeutics had 152 employees as of December 31, 2025. The number of employees increased by 110 or 261.90% compared to the previous year. That makes LENZ Therapeutics the 28,737th largest employer in the world and 3,642nd in the United States.
Employees
152
Change (1Y)
110
Growth (1Y)
261.90%
Revenue / Employee
$141,283
Profits / Employee
-$828,961
Market Cap
99.29M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 152 | 110 | 261.90% |
| Dec 31, 2024 | 42 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Cibus | 118 |
| Immunic | 100 |
| enGene Therapeutics | 82 |
| PolyPid | 75 |
| PMV Pharmaceuticals | 54 |
| OnKure Therapeutics | 45 |
| Vivani Medical | 42 |
| Milestone Pharmaceuticals | 38 |
LENZ News
- 3 days ago - LENZ Therapeutics to Report Third Quarter 2026 Financial Results on October 29, 2026 - GlobeNewsWire
- 4 days ago - Lenz Therapeutics price target lowered to $50 from $60 at TD Cowen - TheFly
- 6 days ago - Lenz Therapeutics price target lowered to $5 from $7 at Piper Sandler - TheFly
- 6 days ago - Lenz Therapeutics price target lowered to $5 from $7 at Piper Sandler - TheFly
- 4 weeks ago - These beaten-down stocks could bounce back in January, if history is any guide - Market Watch
- 2 months ago - Lenz Therapeutics reports Q2 EPS ($1.02), consensus ($1.07) - TheFly
- 2 months ago - Lenz Therapeutics price target lowered to $10 from $20 at Citi - TheFly
- 2 months ago - Lenz Therapeutics price target lowered to $7 from $12 at Piper Sandler - TheFly